Oxidative stress and cell damage in proliferative diabetic retinopathy

Japanese Journal of Clinical Ophthalmology

Volumn 58, Issue 2, 2004, Pages 211-216

  Sato, Hiroaki ^a   Kawasaki, Ryo ^c   Yamashita, Tetsuji ^b   Taki, Setsuko ^c   Yamashita, Hidetoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Mitsubishi Kagaku Bioclin Lab Inc   (Japan)

^c Yamagata Univ School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CYTOKINE; INTERLEUKIN 6; NITRIC OXIDE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; DIABETIC RETINOPATHY; EYE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; LASER COAGULATION; MALE; OXIDATIVE STRESS; RETINA DISEASE; RETINA EPIMACULA MEMBRANE; RETINA MACULA HOLE; RETINA VEIN OCCLUSION; TERSON SYNDROME; VITREORETINOPATHY; VITREOUS BODY; VITREOUS HEMORRHAGE; VITREOUS SURGERY;

EID: 1342302740     PISSN: 03705579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
2. U.K. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS33). Lancet 352: 837-853, 1998
3. Nishikawa T, Edelstein D, Du XL et al: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404: 787-790, 2000
4. Ceriello A: New insights on oxidative stress and diabetic complications may lead to a "causal" anti-oxidant therapy. Diabetes Care 26: 1589-1596, 2003
5. Nishikawa T, Sasahara T, Kiritoshi S: Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complicatons in type 2 diabetes. Diabetes Care 26: 1507-1512, 2003
6. Adamis AP, Miller JW, Bernal MT et al: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118: 445-450, 1994
7. Aiello LP, Avery RL, Arrigg PG et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487, 1994
8. Katsura Y, Okano T, Noritake M et al: Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care 21: 1759-1763, 1998
9. Funatsu H, Yamashita H, Noma H et al: Stimulation and inhibition of angiogenesis in diabetic retinopathy. Jpn J Ophthalmol 45: 577-584, 2001
10. Takashi Y, Tsugiyasu K, Yasutaka K: Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 15: 257-259, 2001
11. Nathan C, Xie QW: Nitric oxide synthases: Roles, tolls, and controls. Cell 78: 915-918, 1994
12. DeLaCruz JP, Arrebola MM, Gonzalez-Correa JA: Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats. Naunyn Schmied-ebergs Arch Pharmacol 367: 204-210, 2003
13. Kobayashi M, Kuroiwa T, Shimokawa R et al: Nitric oxide synthase expression in ischemic rat retinas. Jpn J Ophthalmol 44: 235-244, 2000
14. Hernandez C, Lecube A, Segura RM et al: Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med 19: 655-660, 2002
15. Yilmaz G, Esser P, Kociok N et al: Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy. Am J Ophthalmol 130: 87-90, 2000
16. Kaneko T, Tahara S, Matsuo M: Non-linear accumulation of 8-hydroxy-2′-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat Res 316: 277-285, 1996
17. Loft S, Vistisen K, Ewertz M et al: Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis 13: 2241-2247, 1992
18. Ames BN: Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun 7: 121-128, 1989
19. Dandona P, Thusu K, Cook S et al: Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445, 1996
20. Funatsu H, Yamashita H, Noma H et al: Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 133: 70-77, 2002
21. Cohen T, Nahari D, Cerem LW et al: Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271: 736-741, 1996